CD163 and mature T-cell and NK-cell non-Hodgkin lymphoma: Compared with benign lymph nodes, and consistent with the extent of mono/mac expansion observed in lymphoma-bearing mice, an approximately 5-fold and 2-fold increase in CD163− and CD163+ LAM densities, respectively, were observed in PTCL lymph nodes (Fig. 1D and E).